CytomX Therapeutics (CTMX) Stock Chart & Stock Price History → Pentagon contract could send this $2 AI stock soaring (From Behind the Markets) (Ad) Free CTMX Stock Alerts $1.63 -0.05 (-2.98%) (As of 04:27 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability CytomX Therapeutics Stock Price Performance5 Day Performance-2.40%1 Month Performance-22.75%3 Month Performance+6.54%6 Month Performance+28.35%Year-To-Date Performance+5.16%1 Year Performance0.00% Receive CTMX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CytomX Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsPentagon contract could send this $2 AI stock soaringWhenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...Get all the info here >>> CTMX Stock Chart for Wednesday, April, 24, 2024 CTMX Chart by TradingView CytomX Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/23/2024$1.67$1.68+0.60%$1.73$1.64290,171 shs$113.79 million04/22/2024$1.67$1.67$1.76$1.67257,894 shs$113.11 million04/19/2024$1.73$1.67-3.47%$1.75$1.64505,550 shs$113.11 million04/18/2024$1.76$1.73-1.70%$1.79$1.72198,849 shs$117.17 million04/17/2024$1.86$1.76-5.38%$1.86$1.76585,231 shs$119.21 million04/16/2024$1.97$1.86-5.58%$1.99$1.86335,847 shs$125.98 million Get the Latest News and Ratings for CTMX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CytomX Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/15/2024$2.15$1.97-8.37%$2.14$1.94382,935 shs$133.43 million04/12/2024$2.15$2.15$2.25$2.07923,167 shs$145.62 million04/11/2024$2.10$2.15+2.38%$2.16$2.061.01 million shs$145.62 million04/10/2024$2.03$2.10+3.45%$2.11$1.802.57 million shs$142.24 million04/09/2024$2.06$2.03-1.46%$2.08$2.00196,005 shs$137.49 million04/08/2024$2.06$2.06$2.10$2.05198,344 shs$139.52 million04/05/2024$2.06$2.06$2.14$2.05268,022 shs$139.52 million04/04/2024$2.15$2.06-4.19%$2.18$2.06267,274 shs$139.52 million04/03/2024$2.14$2.15+0.47%$2.18$2.08524,864 shs$145.62 million04/02/2024$2.15$2.14-0.47%$2.15$2.07326,076 shs$144.94 million04/01/2024$2.18$2.15-1.38%$2.20$2.08319,497 shs$145.62 million03/29/2024$2.18$2.18$2.30$2.172.85 million shs$147.65 million03/28/2024$2.19$2.18-0.46%$2.30$2.172.85 million shs$147.65 million03/27/2024$2.11$2.19+3.79%$2.20$2.08590,298 shs$148.31 million03/26/2024$2.14$2.11-1.40%$2.16$1.99645,910 shs$142.89 million03/25/2024$2.11$2.14+1.42%$2.15$2.09357,853 shs$144.92 million03/22/2024$2.24$2.11-5.80%$2.21$2.10287,790 shs$142.89 million03/21/2024$2.27$2.24-1.32%$2.31$2.21667,998 shs$151.69 million03/20/2024$2.18$2.27+4.13%$2.28$2.12650,724 shs$153.72 million03/19/2024$2.02$2.18+7.92%$2.24$2.00916,747 shs$147.63 million03/18/2024$2.07$2.02-2.42%$2.10$1.96982,578 shs$136.79 million03/15/2024$2.06$2.07+0.49%$2.16$2.02491,595 shs$140.18 million03/14/2024$2.10$2.06-1.90%$2.12$1.931.09 million shs$138.00 million03/13/2024$2.15$2.10-2.33%$2.17$2.07665,437 shs$140.68 million03/12/2024$2.51$2.15-14.34%$2.20$1.912.04 million shs$144.03 million03/11/2024$2.50$2.51+0.40%$2.56$2.461.62 million shs$168.15 million03/08/2024$2.56$2.50-2.34%$2.67$2.49570,160 shs$167.48 million03/07/2024$2.70$2.56-5.19%$2.73$2.441.19 million shs$171.49 million03/06/2024$2.72$2.70-0.74%$2.79$2.501.26 million shs$180.87 million03/05/2024$2.74$2.72-0.73%$2.85$2.692.40 million shs$182.21 million03/04/2024$2.65$2.74+3.40%$2.86$2.552.46 million shs$183.55 million03/01/2024$2.45$2.65+8.16%$2.78$2.362.58 million shs$177.52 million02/29/2024$2.54$2.45-3.54%$2.62$2.392.03 million shs$164.13 million02/28/2024$2.25$2.54+12.89%$2.74$2.176.83 million shs$170.16 millionPentagon contract could send this $2 AI stock soaring (Ad)Whenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...Get all the info here >>>02/27/2024$1.65$2.25+36.36%$2.44$1.669.61 million shs$150.73 million02/26/2024$1.50$1.65+10.00%$1.65$1.46516,261 shs$110.53 million02/23/2024$1.48$1.50+1.35%$1.52$1.431.01 million shs$100.49 million02/22/2024$1.45$1.48+2.07%$1.50$1.44135,485 shs$99.15 million02/21/2024$1.47$1.45-1.36%$1.47$1.4581,048 shs$97.14 million02/20/2024$1.47$1.47$1.50$1.46105,303 shs$98.48 million02/19/2024$1.47$1.47$1.53$1.46153,900 shs$98.48 million02/16/2024$1.50$1.47-2.00%$1.51$1.46153,932 shs$98.48 million02/15/2024$1.49$1.50+0.67%$1.53$1.46222,859 shs$100.49 million02/14/2024$1.41$1.49+5.67%$1.49$1.42159,432 shs$99.82 million02/13/2024$1.53$1.41-7.84%$1.46$1.38452,385 shs$94.46 million02/12/2024$1.52$1.53+0.66%$1.57$1.48142,233 shs$102.50 million02/09/2024$1.46$1.52+4.11%$1.56$1.46187,416 shs$101.83 million02/08/2024$1.44$1.46+1.39%$1.50$1.43215,697 shs$97.81 million02/07/2024$1.46$1.44-1.37%$1.46$1.43134,642 shs$96.47 million02/06/2024$1.45$1.46+0.69%$1.51$1.45130,011 shs$97.81 million02/05/2024$1.48$1.45-2.03%$1.48$1.44142,276 shs$97.14 million02/02/2024$1.53$1.48-3.27%$1.53$1.46232,405 shs$99.14 million02/01/2024$1.53$1.53$1.54$1.49221,299 shs$102.50 million01/31/2024$1.57$1.53-2.55%$1.60$1.51144,599 shs$102.50 million01/30/2024$1.61$1.57-2.48%$1.63$1.51255,256 shs$105.17 million01/29/2024$1.59$1.61+1.26%$1.65$1.55300,188 shs$107.85 million01/26/2024$1.53$1.59+3.92%$1.59$1.52205,089 shs$106.51 million01/25/2024$1.53$1.53$1.56$1.52166,170 shs$102.50 million01/24/2024$1.61$1.53-4.97%$1.65$1.52523,835 shs$102.50 million01/23/2024$1.63$1.61-1.23%$1.64$1.59250,483 shs$107.85 million Related Companies: Vistagen Therapeutics Stock Chart Eliem Therapeutics Stock Chart Karyopharm Therapeutics Stock Chart Nuvectis Pharma Stock Chart Repare Therapeutics Stock Chart FibroGen Stock Chart OptiNose Stock Chart Citius Pharmaceuticals Stock Chart Coya Therapeutics Stock Chart Sagimet Biosciences Stock Chart Receive CTMX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CytomX Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CTMX) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe Greatest Bull Market in Crypto History…Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CytomX Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.